Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review
{{output}}
Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disorder of unknown origin that is often treated with a variety of disease-modifying agents. Tumor necrosis factor (TNF) inhibitors are a group of genetically engineered biologic agents that target ... ...